Download FREE Report Sample
Download Free sampleA biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are ?equivalent? in terms of quality, efficacy and safety to an innovative reference medicinal product.
Monoclonal antibodies Biosimilars Market contains market size and forecasts of Monoclonal antibodies (mAbs) Biosimilars in Global, including the following market information:
Global Monoclonal antibodies (mAbs) Biosimilars Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Monoclonal antibodies (mAbs) Biosimilars market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Erythropoietin (EPO) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Monoclonal antibodies (mAbs) Biosimilars include Biocon, Celltrion, Dr. Reddy's Laboratories, Hospira, 3SBio, Accord Healthcare, AET Biotech, Allergan and Amega Biotech. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Monoclonal antibodies (mAbs) Biosimilars companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Monoclonal antibodies (mAbs) Biosimilars Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Monoclonal antibodies (mAbs) Biosimilars Market Segment Percentages, by Type, 2021 (%)
Erythropoietin (EPO)
Human Growth Hormone (HGH)
Granulocyte- Colony Stimulating Factor (G-CSF)
Monoclonal Antibody (mAb)
Insulin
Interferon (IFN)
Others
Global Monoclonal antibodies (mAbs) Biosimilars Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Monoclonal antibodies (mAbs) Biosimilars Market Segment Percentages, by Application, 2021 (%)
Anti-Cancer
Anti-Inflammatory/Autoimmune
Global Monoclonal antibodies (mAbs) Biosimilars Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Monoclonal antibodies (mAbs) Biosimilars Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Monoclonal antibodies (mAbs) Biosimilars revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Monoclonal antibodies (mAbs) Biosimilars revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biocon
Celltrion
Dr. Reddy's Laboratories
Hospira
3SBio
Accord Healthcare
AET Biotech
Allergan
Amega Biotech
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
